ARCHIVES

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Oxaliplatin Regimens Extend Survival Of Advanced Colorectal Cancer, Study Finds

June 27, 2003

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

NCI, Private Groups, Promote Mammograms To Blacks, Hispanics

April 25, 1992

NCI Offers Model Informed Consent Documents

November 6, 1998

In Brief: Fox Chase Joins Temple Health System, Expands Outpatient and Surgical Services

July 6, 2012

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001